FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Steven Geis

Research Profile

Chemicals & Drugs

Procedures

Disorders

Concepts & Ideas

Incidence

Co-author Network

Publications

TOP 3
Roland W Moskowitz; Abraham Sunshine; Andrew Brugger; James B Lefkowith; William W Zhao; G Steven Geis
American pain society pain questionnaire and other pain measures in the assessment of osteoarthritis pain: a pooled analysis of three celecoxib pivotal studies.
Jay L Goldstein; Glenn Eisen; Thomas A Burke; B M Peña; James B Lefkowith; G Steven Geis
Dyspepsia tolerability from the patients' perspective: a comparison of celecoxib with diclofenac.
William B White; Gerald Faich; Andrew Whelton; Clement Maurath; Nancy J Ridge; Kenneth M Verburg; G Steven Geis; James B Lefkowith
Comparison of thromboembolic events in patients treated with celecoxib, a cyclooxygenase-2 specific inhibitor, versus ibuprofen or diclofenac.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Steven Geis (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2003: Roland W Moskowitz; Abraham Sunshine; Andrew Brugger; James B Lefkowith; William W Zhao; G Steven Geis
American pain society pain questionnaire and other pain measures in the assessment of osteoarthritis pain: a pooled analysis of three celecoxib pivotal studies.
American journal of therapeutics 2003;10(1):12-20.
2002: Jay L Goldstein; Glenn Eisen; Thomas A Burke; B M Peña; James B Lefkowith; G Steven Geis
Dyspepsia tolerability from the patients' perspective: a comparison of celecoxib with diclofenac.
Alimentary pharmacology & therapeutics 2002;16(4):819-27.
2002: William B White; Gerald Faich; Andrew Whelton; Clement Maurath; Nancy J Ridge; Kenneth M Verburg; G Steven Geis; James B Lefkowith
Comparison of thromboembolic events in patients treated with celecoxib, a cyclooxygenase-2 specific inhibitor, versus ibuprofen or diclofenac.
The American journal of cardiology 2002;89(4):425-30.
2002: Frank McKenna; L Arguelles; Thomas A Burke; James B Lefkowith; G Steven Geis
Upper gastrointestinal tolerability of celecoxib compared with diclofenac in the treatment of osteoarthritis and rheumatoid arthritis.
Clinical and experimental rheumatology 2002;20(1):35-43.
2001: Alan J Kivitz; Roland W Moskowitz; E Woods; Richard C Hubbard; Kenneth M Verburg; James B Lefkowith; G Steven Geis
Comparative efficacy and safety of celecoxib and naproxen in the treatment of osteoarthritis of the hip.
The Journal of international medical research 2001;29(6):467-79.
2001: Jay L Goldstein; P Correa; William W Zhao; Aimee Burr; Richard C Hubbard; Kenneth M Verburg; G Steven Geis
Reduced incidence of gastroduodenal ulcers with celecoxib, a novel cyclooxygenase-2 inhibitor, compared to naproxen in patients with arthritis.
The American journal of gastroenterology 2001;96(4):1019-27.
2001: J S Gimbel; A Brugger; W Zhao; Kenneth M Verburg; G Steven Geis
Efficacy and tolerability of celecoxib versus hydrocodone/acetaminophen in the treatment of pain after ambulatory orthopedic surgery in adults.
Clinical therapeutics 2001;23(2):228-41.
2001: G W Williams; Richard C Hubbard; S S Yu; W Zhao; G Steven Geis
Comparison of once-daily and twice-daily administration of celecoxib for the treatment of osteoarthritis of the knee.
Clinical therapeutics 2001;23(2):213-27.
2001: Kenneth M Verburg; Timothy J Maziasz; E Weiner; L Loose; G Steven Geis; Peter C Isakson
Cox-2-specific inhibitors: definition of a new therapeutic concept.
American journal of therapeutics 2001;8(1):49-64.
2001: Frank McKenna; D Borenstein; H Wendt; Carl B Wallemark; James B Lefkowith; G Steven Geis
Celecoxib versus diclofenac in the management of osteoarthritis of the knee.
Scandinavian journal of rheumatology 2001;30(1):11-8.
2000: F E Silverstein; Gerald Faich; Jay L Goldstein; Lee S Simon; T Pincus; Andrew Whelton; Robert W Makuch; Glenn Eisen; Naurang M Agrawal; William F Stenson; Aimee Burr; William W Zhao; Jeffrey D Kent; James B Lefkowith; Kenneth M Verburg; G Steven Geis
Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study.
JAMA : the journal of the American Medical Association 2000;284(10):1247-55.
2000: WG Bensen; Sean Z Zhao; Thomas A Burke; RA Zabinski; Robert W Makuch; Clement Maurath; Naurang M Agrawal; G Steven Geis
Upper gastrointestinal tolerability of celecoxib, a COX-2 specific inhibitor, compared to naproxen and placebo.
The Journal of rheumatology 2000;27(8):1876-83.
2000: Jay L Goldstein; F E Silverstein; Naurang M Agrawal; Richard C Hubbard; J Kaiser; Clement Maurath; Kenneth M Verburg; G Steven Geis
Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitor.
The American journal of gastroenterology 2000;95(7):1681-90.
2000: A Karim; D Tolbert; A Piergies; Richard C Hubbard; K Harper; Carl B Wallemark; M Slater; G Steven Geis
Celecoxib does not significantly alter the pharmacokinetics or hypoprothrombinemic effect of warfarin in healthy subjects.
Journal of clinical pharmacology 2000;40(6):655-63.
2000: Andrew Whelton; G Schulman; Carl B Wallemark; E J Drower; Peter C Isakson; Kenneth M Verburg; G Steven Geis
Effects of celecoxib and naproxen on renal function in the elderly.
Archives of internal medicine 2000;160(10):1465-70.
2000: Andrew Whelton; Clement Maurath; Kenneth M Verburg; G Steven Geis
Renal safety and tolerability of celecoxib, a novel cyclooxygenase-2 inhibitor.
American journal of therapeutics 2000;7(3):159-75.
2000: Willis C Maddrey; Clement Maurath; Kenneth M Verburg; G Steven Geis
The hepatic safety and tolerability of the novel cyclooxygenase-2 inhibitor celecoxib.
American journal of therapeutics 2000;7(3):153-8.
2000: P T Leese; Richard C Hubbard; A Karim; Peter C Isakson; S S Yu; G Steven Geis
Effects of celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: a randomized, controlled trial.
Journal of clinical pharmacology 2000;40(2):124-32.
1999: Paul Emery; H Zeidler; T K Kvien; M Guslandi; R Naudin; H Stead; Kenneth M Verburg; Peter C Isakson; Richard C Hubbard; G Steven Geis
Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison.
Lancet 1999;354(9196):2106-11.
1999: A Karim; D S Tolbert; T L Hunt; Richard C Hubbard; K M Harper; G Steven Geis
Celecoxib, a specific COX-2 inhibitor, has no significant effect on methotrexate pharmacokinetics in patients with rheumatoid arthritis.
The Journal of rheumatology 1999;26(12):2539-43.
1999: Lee S Simon; A L Weaver; D Y Graham; Alan J Kivitz; P E Lipsky; Richard C Hubbard; Peter C Isakson; Kenneth M Verburg; SS Yu; William W Zhao; G Steven Geis
Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial.
JAMA : the journal of the American Medical Association 1999;282(20):1921-8.
1999: WG Bensen; J J Fiechtner; J I McMillen; William W Zhao; SS Yu; E M Woods; Richard C Hubbard; Peter C Isakson; Kenneth M Verburg; G Steven Geis
Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial.
Mayo Clinic proceedings. Mayo Clinic 1999;74(11):1095-105.
1999: D E Cheatum; C Arvanitakis; M Gumpel; H Stead; G Steven Geis
An endoscopic study of gastroduodenal lesions induced by nonsteroidal anti-inflammatory drugs.
Clinical therapeutics 1999;21(6):992-1003.
1998: Lee S Simon; F L Lanza; P E Lipsky; Richard C Hubbard; Sheela Talwalker; B D Schwartz; Peter C Isakson; G Steven Geis
Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects.
Arthritis and rheumatism 1998;41(9):1591-602.
1998: T S Bocanegra; A L Weaver; Elizabeth Tindall; D H Sikes; J A Ball; Carl B Wallemark; G Steven Geis; John G Fort
Diclofenac/misoprostol compared with diclofenac in the treatment of osteoarthritis of the knee or hip: a randomized, placebo controlled trial. Arthrotec Osteoarthritis Study Group.
The Journal of rheumatology 1998;25(8):1602-11.
1995: N M Agrawal; H E Van Kerckhove; L J Erhardt; G Steven Geis
Misoprostol coadministered with diclofenac for prevention of gastroduodenal ulcers. A one-year study.
Digestive diseases and sciences 1995;40(5):1125-31.
1993: J A Melo Gomes; S H Roth; J Zeeh; G A Bruyn; E M Woods; G Steven Geis
Double-blind comparison of efficacy and gastroduodenal safety of diclofenac/misoprostol, piroxicam, and naproxen in the treatment of osteoarthritis.
Annals of the rheumatic diseases 1993;52(12):881-5.
1993: G Steven Geis
Efficacy and upper GI safety of diclofenac/misoprostol, piroxicam and naproxen in patients with osteoarthritis.
Drugs 1993;45 Suppl 1():15; discussion 15-6, 36-7.
1992: W Bolten; J A Gomes; H Stead; G Steven Geis
The gastroduodenal safety and efficacy of the fixed combination of diclofenac and misoprostol in the treatment of osteoarthritis.
British journal of rheumatology 1992;31(11):753-8.
1992: L F Martin; F V Booth; H D Reines; L G Deysach; R L Kochman; L J Erhardt; G Steven Geis
Stress ulcers and organ failure in intubated patients in surgical intensive care units.
Annals of surgery 1992;215(4):332-7.
1992: W Verdickt; C Moran; Holm Häntzschel; A M Fraga; H Stead; G Steven Geis
A double-blind comparison of the gastroduodenal safety and efficacy of diclofenac and a fixed dose combination of diclofenac and misoprostol in the treatment of rheumatoid arthritis.
Scandinavian journal of rheumatology 1992;21(2):85-91.
1991: F L Lanza; R L Kochman; G Steven Geis; E M Rack; L G Deysach
A double-blind, placebo-controlled, 6-day evaluation of two doses of misoprostol in gastroduodenal mucosal protection against damage from aspirin and effect on bowel habits.
The American journal of gastroenterology 1991;86(12):1743-8.
1991: G Steven Geis; H Stead; C B Wallemark; P A Nicholson
Prevalence of mucosal lesions in the stomach and duodenum due to chronic use of NSAID in patients with rheumatoid arthritis or osteoarthritis, and interim report on prevention by misoprostol of diclofenac associated lesions.
The Journal of rheumatology. Supplement 1991;28():11-4.